JP2010503689A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010503689A5 JP2010503689A5 JP2009528340A JP2009528340A JP2010503689A5 JP 2010503689 A5 JP2010503689 A5 JP 2010503689A5 JP 2009528340 A JP2009528340 A JP 2009528340A JP 2009528340 A JP2009528340 A JP 2009528340A JP 2010503689 A5 JP2010503689 A5 JP 2010503689A5
- Authority
- JP
- Japan
- Prior art keywords
- tsh
- patient
- pharmaceutical composition
- pharmaceutically acceptable
- serum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920000642 polymer Polymers 0.000 claims description 22
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 9
- 229920001661 Chitosan Polymers 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 5
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 4
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 4
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 4
- 229940105329 carboxymethylcellulose Drugs 0.000 claims description 4
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 4
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 4
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 4
- 229920001223 polyethylene glycol Polymers 0.000 claims description 4
- 229920000609 methyl cellulose Polymers 0.000 claims description 3
- 239000001923 methylcellulose Substances 0.000 claims description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 2
- 229920001817 Agar Polymers 0.000 claims description 2
- 229920000936 Agarose Polymers 0.000 claims description 2
- 229920000945 Amylopectin Polymers 0.000 claims description 2
- 229920000856 Amylose Polymers 0.000 claims description 2
- 229920002567 Chondroitin Polymers 0.000 claims description 2
- 229920002307 Dextran Polymers 0.000 claims description 2
- 229920000896 Ethulose Polymers 0.000 claims description 2
- 239000001859 Ethyl hydroxyethyl cellulose Substances 0.000 claims description 2
- 108010010803 Gelatin Proteins 0.000 claims description 2
- 229920002971 Heparan sulfate Polymers 0.000 claims description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 2
- 229920000037 Polyproline Polymers 0.000 claims description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 2
- 239000008272 agar Substances 0.000 claims description 2
- 235000010419 agar Nutrition 0.000 claims description 2
- 229940072056 alginate Drugs 0.000 claims description 2
- 235000010443 alginic acid Nutrition 0.000 claims description 2
- 229920000615 alginic acid Polymers 0.000 claims description 2
- 229920001400 block copolymer Polymers 0.000 claims description 2
- 229940084030 carboxymethylcellulose calcium Drugs 0.000 claims description 2
- 235000010418 carrageenan Nutrition 0.000 claims description 2
- 239000000679 carrageenan Substances 0.000 claims description 2
- 229920001525 carrageenan Polymers 0.000 claims description 2
- 229940113118 carrageenan Drugs 0.000 claims description 2
- 229920002678 cellulose Chemical class 0.000 claims description 2
- 239000001913 cellulose Chemical class 0.000 claims description 2
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 235000019326 ethyl hydroxyethyl cellulose Nutrition 0.000 claims description 2
- 239000008273 gelatin Substances 0.000 claims description 2
- 229920000159 gelatin Polymers 0.000 claims description 2
- 235000019322 gelatine Nutrition 0.000 claims description 2
- 235000011852 gelatine desserts Nutrition 0.000 claims description 2
- 150000004676 glycans Chemical class 0.000 claims description 2
- 229920000669 heparin Polymers 0.000 claims description 2
- 229960002897 heparin Drugs 0.000 claims description 2
- 229920002674 hyaluronan Polymers 0.000 claims description 2
- 229960003160 hyaluronic acid Drugs 0.000 claims description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 2
- 229920003063 hydroxymethyl cellulose Polymers 0.000 claims description 2
- 229940031574 hydroxymethyl cellulose Drugs 0.000 claims description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 2
- 229960003943 hypromellose Drugs 0.000 claims description 2
- 239000001814 pectin Substances 0.000 claims description 2
- 235000010987 pectin Nutrition 0.000 claims description 2
- 229920001277 pectin Polymers 0.000 claims description 2
- 108010026466 polyproline Proteins 0.000 claims description 2
- 229920001451 polypropylene glycol Polymers 0.000 claims description 2
- 229920001282 polysaccharide Polymers 0.000 claims description 2
- 239000005017 polysaccharide Substances 0.000 claims description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 22
- 239000000203 mixture Substances 0.000 claims 14
- 210000002966 serum Anatomy 0.000 claims 11
- 238000000034 method Methods 0.000 claims 9
- 210000001685 thyroid gland Anatomy 0.000 claims 8
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical group [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims 5
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims 5
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims 5
- 241000124008 Mammalia Species 0.000 claims 4
- 208000024770 Thyroid neoplasm Diseases 0.000 claims 2
- 210000004369 blood Anatomy 0.000 claims 2
- 239000008280 blood Substances 0.000 claims 2
- 238000013270 controlled release Methods 0.000 claims 2
- 238000009472 formulation Methods 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 241000894007 species Species 0.000 claims 2
- 201000002510 thyroid cancer Diseases 0.000 claims 2
- 229940094517 chondroitin 4-sulfate Drugs 0.000 claims 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- -1 glycosa Nogurikan Polymers 0.000 claims 1
- 238000010255 intramuscular injection Methods 0.000 claims 1
- 239000007927 intramuscular injection Substances 0.000 claims 1
- 230000036470 plasma concentration Effects 0.000 claims 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84607706P | 2006-09-19 | 2006-09-19 | |
| PCT/US2007/020221 WO2008036271A1 (en) | 2006-09-19 | 2007-09-18 | Formulations for therapeutic administration of thyroid stimulating hormone (tsh) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010503689A JP2010503689A (ja) | 2010-02-04 |
| JP2010503689A5 true JP2010503689A5 (https=) | 2010-11-11 |
Family
ID=39018092
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009528340A Pending JP2010503689A (ja) | 2006-09-19 | 2007-09-18 | 甲状腺刺激ホルモン（ｔｓｈ）の治療的投与のための配合物 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20100048455A1 (https=) |
| EP (1) | EP2063909B1 (https=) |
| JP (1) | JP2010503689A (https=) |
| AR (1) | AR062894A1 (https=) |
| BR (1) | BRPI0717077A2 (https=) |
| CA (1) | CA2663323A1 (https=) |
| DK (1) | DK2063909T3 (https=) |
| ES (1) | ES2396502T3 (https=) |
| MX (1) | MX2009002985A (https=) |
| PL (1) | PL2063909T3 (https=) |
| PT (1) | PT2063909E (https=) |
| SI (1) | SI2063909T1 (https=) |
| WO (1) | WO2008036271A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6255348B2 (ja) * | 2011-12-19 | 2017-12-27 | ジェンザイム・コーポレーション | 甲状腺刺激ホルモン組成物 |
| WO2019116048A1 (en) * | 2017-12-14 | 2019-06-20 | The London Psychiatry Centre | Treatment of psychiatric conditions such as resistant depression, bipolar disorder and/or major depressive disorder via application of repetitive transcranial magnetic stimulation with thyroid hormone treatment and/or quetiapine |
| CN113740523A (zh) * | 2021-09-14 | 2021-12-03 | 首都医科大学附属北京朝阳医院 | 一种基于量值溯源的tsh多系统赋值方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0228604A3 (en) * | 1985-12-11 | 1988-10-12 | Sloan-Kettering Institute For Cancer Research | Isolation of a gene encoding human thyrotropin beta subunit |
| US5595756A (en) * | 1993-12-22 | 1997-01-21 | Inex Pharmaceuticals Corporation | Liposomal compositions for enhanced retention of bioactive agents |
| US5968895A (en) * | 1996-12-11 | 1999-10-19 | Praecis Pharmaceuticals, Inc. | Pharmaceutical formulations for sustained drug delivery |
| CN1277633A (zh) * | 1997-09-22 | 2000-12-20 | 马里兰大学巴尔的摩分校 | 促甲状腺激素的突变体及其制备方法 |
| WO2000000222A1 (en) * | 1998-06-30 | 2000-01-06 | Amgen Inc. | Thermosensitive biodegradable hydrogels for sustained delivery of biologically active agents |
| ITMI20011401A1 (it) * | 2001-07-02 | 2003-01-02 | Altergon Sa | Formulazioni farmaceutiche per ormoni tiroidei |
| US20080167223A1 (en) * | 2004-04-16 | 2008-07-10 | Mount Sinai School Of Medicine | Methods and Compositions for Using Tsh in the Inhibition of Tnf Activity |
-
2007
- 2007-09-18 DK DK07838433.6T patent/DK2063909T3/da active
- 2007-09-18 PL PL07838433T patent/PL2063909T3/pl unknown
- 2007-09-18 WO PCT/US2007/020221 patent/WO2008036271A1/en not_active Ceased
- 2007-09-18 SI SI200731102T patent/SI2063909T1/sl unknown
- 2007-09-18 ES ES07838433T patent/ES2396502T3/es active Active
- 2007-09-18 EP EP07838433A patent/EP2063909B1/en not_active Not-in-force
- 2007-09-18 PT PT78384336T patent/PT2063909E/pt unknown
- 2007-09-18 MX MX2009002985A patent/MX2009002985A/es active IP Right Grant
- 2007-09-18 JP JP2009528340A patent/JP2010503689A/ja active Pending
- 2007-09-18 BR BRPI0717077-7A patent/BRPI0717077A2/pt active Search and Examination
- 2007-09-18 CA CA002663323A patent/CA2663323A1/en not_active Abandoned
- 2007-09-18 US US12/441,836 patent/US20100048455A1/en not_active Abandoned
- 2007-09-19 AR ARP070104133A patent/AR062894A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Liu et al. | Acceleration of skin regeneration in full‐thickness burns by incorporation of bFGF‐loaded alginate microspheres into a CMCS–PVA hydrogel | |
| JP6027013B2 (ja) | グルカン組成物 | |
| AU2008331491B2 (en) | Polysaccharide gel compositions and methods for sustained delivery of drugs | |
| Dumitriu et al. | Polymeric biomaterials | |
| US6869938B1 (en) | Compositions of polyacids and polyethers and methods for their use in reducing adhesions | |
| JP5425216B2 (ja) | 癒着防止用組成物 | |
| DK2373321T3 (en) | Biovedhæftende platelet lysate and compositions thereof for the treatment of mucostitis | |
| Dumitriu | Polysaccharides as biomaterials | |
| KR101452041B1 (ko) | 유착방지재 및 유착방지 방법 | |
| CN103585675A (zh) | 一种抗菌组合物及使用其制备的缓释抗菌膜和植入材料 | |
| EP1390048A2 (en) | Oral formulations containing mucopolysaccharide for small intestine delivery and their use in the treatment circulatory disorders | |
| CN108926735B (zh) | 改性壳聚糖-海藻酸盐-龙血竭复合纳米止血材料及其制备方法 | |
| CN103611190A (zh) | 一种使用抗菌组合物制备缓释抗菌膜和植入材料的方法 | |
| JP2006525333A5 (https=) | ||
| US20040096422A1 (en) | Compositions of polyacids and polyethers and methods for their use in reducing pain | |
| JP2011037849A (ja) | 消化性潰瘍及び十二指腸潰瘍の治療及び予防に使用されるヒアルロン酸混合物 | |
| JP2010503689A5 (https=) | ||
| JP3975318B2 (ja) | 組織癒着防止剤 | |
| JP7774899B2 (ja) | 組織形成剤 | |
| US12343916B2 (en) | Anti-adhesive hydrogel composition | |
| JP2008515807A (ja) | 腎臓疾患の治療にグリコサミノグリカンを用いる方法 | |
| JP6210794B2 (ja) | 線維化剤 | |
| JP4676581B2 (ja) | 肝実質細胞増殖因子含有医薬組成物 | |
| CN120531758A (zh) | 一种粘弹补充剂的制备方法 | |
| HK40068653B (en) | Anti-adhesive hydrogel composition |